Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Zangerle

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
European Journal of Cancer & Clinical Oncology|October 1, 1985
Validation of radioimmunoassay for human lactalbumin in the serum by testing the endogenous antibodies interferenceP F Zangerle, P Franchimont
European Journal of Cancer|July 1, 1977
Present and future clinical relevance of tumour markersP Franchimont, P F Zangerle
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1979
Casein and breast cancerJ C Hendrick, P F Zangerle, P Franchimont
Antibiotics and Chemotherapy|January 1, 1978
Casein and other tumor markers in relation to cancer of the breastP F Zangerle, A Thirion, J C Hendrick, et al.
Lancet (London, England)|November 22, 1986
Acute transverse myelitis as presenting neurological feature of Lyme diseaseJ J Rousseau, C Lust, P F Zangerle, et al.
Annales De Medecine Interne|January 1, 1984
[Products of exocrine secretion of the breast and breast cancer]P Franchimont, J Collette, P F Zangerle, et al.
Cancer|June 1, 1977
Simultaneous assays of cancer associated antigens in benign and malignant breast diseasesP Franchimont, P F Zangerle, J C Hendrick, et al.
British Journal of Cancer|August 1, 1974
Proceedings: Measurement of carcinoembryonic antigen (CEA) in normal subjects and in various neoplastic and non-neoplastic disordersP Franchimont, P F Zangerle, M L Debruche, et al.
Revue Medicale De Liege|July 1, 1983
[Monitoring of rectocolic cancers treated surgically: practical application of carcino-embryonic antigen]J Y Reginster, C Desaive, J Collette, et al.
Annales D'Endocrinologie|January 1, 1984
[Are chorionic gonadotropin (HCG) and its alpha and beta subunits useful markers in non-trophoblastic tumors?]P Franchimont, J Collette, J Hustin, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
European Journal of Cancer & Clinical Oncology|October 1, 1985
Validation of radioimmunoassay for human lactalbumin in the serum by testing the endogenous antibodies interferenceP F Zangerle, P Franchimont
European Journal of Cancer|July 1, 1977
Present and future clinical relevance of tumour markersP Franchimont, P F Zangerle
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1979
Casein and breast cancerJ C Hendrick, P F Zangerle, P Franchimont
Antibiotics and Chemotherapy|January 1, 1978
Casein and other tumor markers in relation to cancer of the breastP F Zangerle, A Thirion, J C Hendrick, et al.
Lancet (London, England)|November 22, 1986
Acute transverse myelitis as presenting neurological feature of Lyme diseaseJ J Rousseau, C Lust, P F Zangerle, et al.
Annales De Medecine Interne|January 1, 1984
[Products of exocrine secretion of the breast and breast cancer]P Franchimont, J Collette, P F Zangerle, et al.
Cancer|June 1, 1977
Simultaneous assays of cancer associated antigens in benign and malignant breast diseasesP Franchimont, P F Zangerle, J C Hendrick, et al.
British Journal of Cancer|August 1, 1974
Proceedings: Measurement of carcinoembryonic antigen (CEA) in normal subjects and in various neoplastic and non-neoplastic disordersP Franchimont, P F Zangerle, M L Debruche, et al.
Revue Medicale De Liege|July 1, 1983
[Monitoring of rectocolic cancers treated surgically: practical application of carcino-embryonic antigen]J Y Reginster, C Desaive, J Collette, et al.
Annales D'Endocrinologie|January 1, 1984
[Are chorionic gonadotropin (HCG) and its alpha and beta subunits useful markers in non-trophoblastic tumors?]P Franchimont, J Collette, J Hustin, et al.
Pageof 3